共 150 条
[21]
Bateman A(2017)Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease Arthritis Res Ther 19 9-517
[22]
Cheung ST(2019)Hyperferritinaemia: an iron sword of autoimmunity Curr Pharm Des 25 2909-13
[23]
Bennett HPJ(2017)Hyperferritinemia and inflammation Int Immunol 29 401-200
[24]
Jian J(2019)Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis Mod Rheumatol 29 814-632
[25]
Li G(2019)Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease Eur J Dermatol 29 511-517
[26]
Hettinghouse A(2012)Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases Respir Investig 50 3-257
[27]
Liu C(2014)Biomarkers in connective tissue disease-associated interstitial lung disease Semin Respir Crit Care Med 35 181-undefined
[28]
Wei J(2019)KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis/dermatomyositis, but is not a short-term disease-activity biomarker Mod Rheumatol 29 625-undefined
[29]
Hettinghouse A(2016)Progranulin deficiency leads to severe inflammation, lung injury and cell death in a mouse model of endotoxic shock J Cell Mol Med 20 506-undefined
[30]
Liu C(2018)Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody J Med Invest 65 251-undefined